Literature DB >> 11528213

Lack of association between Gly460Trp polymorphism of alpha-adducin gene and salt sensitivity of blood pressure in Polish hypertensives.

A Ciechanowicz1, K Widecka, R Drozd, G Adler, L Cyryłowski, S Czekalski.   

Abstract

BACKGROUND: Previous studies have suggested that alpha-adducin (alpha-ADD) polymorphism may identify patients with a salt-sensitive form of hypertension. AIM: To investigate the association between Gly460Trp polymorphism of alpha-ADD and the pattern of blood pressure response to subacute (1 week) salt loading and depletion in young adult thin Polish hypertensives.
METHODS: The study group consisted of 44 subjects with salt-sensitive hypertension (SS) and 24 subjects with non-salt-sensitive hypertension (SR). Genomic DNA isolated from peripheral blood leukocytes was amplified by PCR method with primers flanking the polymorphic region. The mismatch near to 3'-end of the upstream primer was introduced to create a Nla III restriction site in Trp 460 allele. In addition, excreted fraction of filtered sodium (FENa), plasma renin activity (PRA) and plasma concentrations of aldosterone (ALDO) were determined on normal, low and high salt diets.
RESULTS: FENa on normal or high salt diets were significantly lower in the SS hypertensives as compared with the SR patients. PRA in SS group was also significantly lower as compared with results in SR group, but only on high salt diet. No significant difference was detected in frequencies of genotypes and alleles of alpha-ADD gene between SS and SR subjects. An additional analysis with regard to genotype (Gly/Gly vs. Gly/Trp+Trp/Trp) showed no significant difference in changes of blood pressure as well as in results of laboratory investigations.
CONCLUSION: Our results suggest lack of association between Gly460Trp polymorphism of alpha-adducin gene and salt sensitivity of blood pressure in Polish hypertensives. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11528213     DOI: 10.1159/000054228

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  6 in total

Review 1.  Drug-gene interactions between genetic polymorphisms and antihypertensive therapy.

Authors:  Hedi Schelleman; Bruno H Ch Stricker; Anthonius De Boer; Abraham A Kroon; Monique W M Verschuren; Cornelia M Van Duijn; Bruce M Psaty; Olaf H Klungel
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Association between alpha-adducin gene polymorphism (Gly460Trp) and genetic predisposition to salt sensitivity: a meta-analysis.

Authors:  R Wang; B Zhong; Y Liu; C Wang
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

3.  Alpha-adducin Gly460Trp polymorphism and hypertension risk: a meta-analysis of 22 studies including 14303 cases and 15961 controls.

Authors:  Kuo Liu; Jielin Liu; Yan Huang; Ya Liu; Yuqing Lou; Zuoguang Wang; Hong Zhang; Shan Yan; Zhizhong Li; Shaojun Wen
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

4.  Novel genetic variants in the alpha-adducin and guanine nucleotide binding protein beta-polypeptide 3 genes and salt sensitivity of blood pressure.

Authors:  Tanika N Kelly; Treva K Rice; Dongfeng Gu; James E Hixson; Jing Chen; Depei Liu; Cashell E Jaquish; Lydia A Bazzano; Dongsheng Hu; Jixiang Ma; C Charles Gu; Jianfeng Huang; L Lee Hamm; Jiang He
Journal:  Am J Hypertens       Date:  2009-07-02       Impact factor: 2.689

5.  Gly460Trp polymorphism of the ADD1 gene and essential hypertension in an Indian population: A meta-analysis on hypertension risk.

Authors:  P Ramu; G Umamaheswaran; D G Shewade; R P Swaminathan; J Balachander; C Adithan
Journal:  Indian J Hum Genet       Date:  2010-01

Review 6.  A Review on Adducin from Functional to Pathological Mechanisms: Future Direction in Cancer.

Authors:  Karrie Mei-Yee Kiang; Gilberto Ka-Kit Leung
Journal:  Biomed Res Int       Date:  2018-05-16       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.